Literature DB >> 19091579

The synthesis of ursolic acid derivatives with cytotoxic activity and the investigation of their preliminary mechanism of action.

Yan-Qiu Meng1, Dan Liu, Ling-Li Cai, Hong Chen, Bo Cao, Yi-Zheng Wang.   

Abstract

Nineteen ursolic acid derivatives (15 novel compounds) modified at the C-3 and the C-28 positions were synthesized. The cytotoxic activity of the derivatives was evaluated against HeLa, BGC-823 and SKOV3 cells by MTT assay. Inducing apoptosis and affecting cell cycle distribution by the derivatives in HeLa cells were assessed by flow cytometry and DNA fragmentation. Compounds 10b and 11b were particularly active to inhibit HeLa cells growth through inducing apoptosis and arresting cell cycle progression. The typical 'sub-G1 peak' and DNA ladder formation were checked and cell cycle was arrested at the S phase in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091579     DOI: 10.1016/j.bmc.2008.11.036

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

Review 1.  Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.

Authors:  Haijun Chen; Yu Gao; Ailan Wang; Xiaobin Zhou; Yunquan Zheng; Jia Zhou
Journal:  Eur J Med Chem       Date:  2015-01-16       Impact factor: 6.514

2.  Side chain-functionalized aniline-derived ursolic acid derivatives as multidrug resistance reversers that block the nuclear factor-kappa B (NF-κB) pathway and cell proliferation.

Authors:  Ri-Zhen Huang; Shi-Xian Hua; Zhi-Xin Liao; Xiao-Chao Huang; Heng-Shan Wang
Journal:  Medchemcomm       Date:  2017-05-12       Impact factor: 3.597

3.  Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells.

Authors:  Xianghong Wang; Liling Li; Bo Wang; Jinyi Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

4.  Design, Synthesis, Molecular Modelling, and Biological Evaluation of Oleanolic Acid-Arylidene Derivatives as Potential Anti-Inflammatory Agents.

Authors:  Reyaz Hassan Mir; Goutami Godavari; Nasir Ali Siddiqui; Bilal Ahmad; Ramzi A Mothana; Riaz Ullah; Omer M Almarfadi; Sanjay M Jachak; Mubashir Hussain Masoodi
Journal:  Drug Des Devel Ther       Date:  2021-02-04       Impact factor: 4.162

5.  Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.

Authors:  Jichuang Wang; Zhou Jiang; Liping Xiang; Yuanfang Li; Minrui Ou; Xiang Yang; Jingwei Shao; Yusheng Lu; Lifeng Lin; Jianzhong Chen; Yun Dai; Lee Jia
Journal:  Sci Rep       Date:  2014-05-21       Impact factor: 4.379

6.  Cytotoxic activities of naturally occurring oleanane-, ursane-, and lupane-type triterpenes on HepG2 and AGS cells.

Authors:  Heejung Yang; Hyun Woo Kim; Young Choong Kim; Sang Hyun Sung
Journal:  Pharmacogn Mag       Date:  2017 Jan-Mar       Impact factor: 1.085

Review 7.  Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View.

Authors:  Manuela Labbozzetta; Monica Notarbartolo; Paola Poma
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

8.  Synthesis and tumor cytotoxicity of novel amide derivatives of β-hederin.

Authors:  Yang Liu; Wen-Xiang Lu; Mao-Cai Yan; Yang Yu; Takashi Ikejima; Mao-Sheng Cheng
Journal:  Molecules       Date:  2010-11-03       Impact factor: 4.411

9.  Synthesis and Evaluation of Novel Triterpene Analogues of Ursolic Acid as Potential Antidiabetic Agent.

Authors:  Panpan Wu; Jie Zheng; Tianming Huang; Dianmeng Li; Qingqing Hu; Anming Cheng; Zhengyun Jiang; Luoying Jiao; Suqing Zhao; Kun Zhang
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  Antineoplastic agents. 595. Structural modifications of betulin and the X-ray crystal structure of an unusual betulin amine dimer.

Authors:  George R Pettit; Noeleen Melody; Frank Hempenstall; Jean-Charles Chapuis; Thomas L Groy; Lee Williams
Journal:  J Nat Prod       Date:  2014-04-02       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.